Roche has recently entered into a groundbreaking multi-year collaboration with Oxford BioTherapeutics (OBT), valued at over a billion dollars, to spearhead the development of novel antibody-based cancer treatments. This significant partnership focuses on the creation of innovative therapies such as
Glucose, a simple sugar widely recognized for its role as the primary energy source for most living cells, has recently been discovered to play a critical role beyond its conventional function. In groundbreaking research conducted by a team at Stanford Medicine, glucose has been identified as a
The National Farmers' Union (NFU) has recently called for enhanced biosecurity measures among farmers after detecting a case of avian influenza (H5N1) in a sheep in Yorkshire. This discovery came to light following routine surveillance, wherein avian influenza had previously been confirmed in
The notion of genetically engineering an unborn child's sexual orientation has stirred debates among ethicists, scientists, and religious groups. This discourse stems from the suggestion that, with advancements in scientific knowledge, it might be possible to determine an unborn child's sexual
The COVID-19 pandemic underscored significant challenges that tested the resilience of the global biotech industry, causing unprecedented disruptions but also highlighting areas ripe for growth and innovation. Against this backdrop, the Gulf Cooperation Council (GCC) countries, with Saudi Arabia at
GRObio, a spinout from the George Church Lab at Harvard University, has encountered significant hurdles lately. Founded in 2016, GRObio focuses on developing therapeutic proteins built on nonstandard amino acids (NSAAs). Despite its pioneering approach, the company is undergoing a period of
